Global Hormonal Contraception Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Hormonal Contraception Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Hormonal Contraception is a type of birth control that uses hormones to prevent pregnancy.
Hormonal Contraception report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Hormonal Contraception market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Hospital and Clinics are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Hormonal Contraception industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Hormonal Contraception key manufacturers include Bayer AG, Merck & Co., Inc., Pfizer, Inc., Agile Therapeutics, Inc., Teva Pharmaceutical Industries Ltd., Amgen, Cipla Ltd., Glenmark Pharmaceuticals Inc. and Lupin Limited(Lupin Pharmaceuticals, Inc.), etc. Bayer AG, Merck & Co., Inc., Pfizer, Inc. are top 3 players and held % sales share in total in 2022.
Hormonal Contraception can be divided into Androgens, Estrogens, Progestrogens and Antiandrogens, etc. Androgens is the mainstream product in the market, accounting for % sales share globally in 2022.
Hormonal Contraception is widely used in various fields, such as Hospital, Clinics, Gynaecology Centers and Others, etc. Hospital provides greatest supports to the Hormonal Contraception industry development. In 2022, global % sales of Hormonal Contraception went into Hospital filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Hormonal Contraception market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
![](http//localhost/mraccuracy/images/Market%20Recearch%20Graph.jpg)
Bayer AG
Merck & Co., Inc.
Pfizer, Inc.
Agile Therapeutics, Inc.
Teva Pharmaceutical Industries Ltd.
Amgen
Cipla Ltd.
Glenmark Pharmaceuticals Inc.
Lupin Limited(Lupin Pharmaceuticals, Inc.)
Novartis AG
Mylan N.V.
Johnson & Johnson
Ansell LTD
Mayer Laboratories, Inc.
Segment by Type
by Hormone
Androgens
Estrogens
Progestrogens
Antiandrogens
Gonadotropins
by Method
Combined Oral
Oral Pill
Implanted
Injected
Intrauterine
Transdermal Patch
Hospital
Clinics
Gynaecology Centers
Others
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Hormonal Contraception market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Hormonal Contraception, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Hormonal Contraception industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Hormonal Contraception in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Hormonal Contraception introduction, etc. Hormonal Contraception Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Hormonal Contraception market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.![](http://localhost/mraccuracy/images/About Report.webp)
Hormonal Contraception report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Hormonal Contraception market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Hospital and Clinics are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Hormonal Contraception industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Hormonal Contraception key manufacturers include Bayer AG, Merck & Co., Inc., Pfizer, Inc., Agile Therapeutics, Inc., Teva Pharmaceutical Industries Ltd., Amgen, Cipla Ltd., Glenmark Pharmaceuticals Inc. and Lupin Limited(Lupin Pharmaceuticals, Inc.), etc. Bayer AG, Merck & Co., Inc., Pfizer, Inc. are top 3 players and held % sales share in total in 2022.
Hormonal Contraception can be divided into Androgens, Estrogens, Progestrogens and Antiandrogens, etc. Androgens is the mainstream product in the market, accounting for % sales share globally in 2022.
Hormonal Contraception is widely used in various fields, such as Hospital, Clinics, Gynaecology Centers and Others, etc. Hospital provides greatest supports to the Hormonal Contraception industry development. In 2022, global % sales of Hormonal Contraception went into Hospital filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Hormonal Contraception market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
![](http//localhost/mraccuracy/images/Market%20Recearch%20Graph.jpg)
By Company
Bayer AG
Merck & Co., Inc.
Pfizer, Inc.
Agile Therapeutics, Inc.
Teva Pharmaceutical Industries Ltd.
Amgen
Cipla Ltd.
Glenmark Pharmaceuticals Inc.
Lupin Limited(Lupin Pharmaceuticals, Inc.)
Novartis AG
Mylan N.V.
Johnson & Johnson
Ansell LTD
Mayer Laboratories, Inc.
Segment by Type
by Hormone
Androgens
Estrogens
Progestrogens
Antiandrogens
Gonadotropins
by Method
Combined Oral
Oral Pill
Implanted
Injected
Intrauterine
Transdermal Patch
Segment by Application
Hospital
Clinics
Gynaecology Centers
Others
Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Hormonal Contraception market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Hormonal Contraception, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Hormonal Contraception industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Hormonal Contraception in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Hormonal Contraception introduction, etc. Hormonal Contraception Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Hormonal Contraception market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
![](http://localhost/mraccuracy/images/About Report.webp)